FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports.
Share this article
Regulation
Score 85
Bullish
FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports
Mar 25, 2026 19:11 UTC
SNY, XLV, AMGN
Short term
Related Articles
Score 65
Bearish
Kenya Plans to Stabilize Fuel Price as Outages Hit Some Stations
Mar 27, 08:23
Score 65
Helium Shortage Sparks Widespread Concerns Beyond Birthday Parties
Mar 27, 08:00
Score 75
Bullish
Hong Kong Mulls Tax Exemption for Fund Managers to Boost Hub
Mar 27, 06:47
Score 72
Bearish
Australia Ramps Up Private Credit Scrutiny, Demanding More Data
Mar 27, 02:55
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.